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We examined loss of heterozygosity at 13 loci on 5 chromo-
somes in hepatocellular carcinomas (HCCs) from 56 patients. In 
42 of these cases, regenerative nodules of liver ci r rhosis were 
also analyzed. High frequencies of allelic losses were detected 
on chromosomes IJq (47%), 16q (40%) and 17p (64%), whereas 
losses on chromosome 4p and I I p were observed in less than 
22% of cases in HCCs. ln contrast, LOH was not detected on any 
loci in cirrhotic nodules. On chromosome IJq, the common 
region of allelic loss was mapped to the region including the 
retinoblastoma (RB) locus, by using 8 polymorphic probes. 
Furthermore, one case with IJq loss had an interstitial deletion 
of the RB gene, indicating the involvement of inactivation of the 
RB gene in hepatotumorigenesis. Losses were associated with 
portal-vein thrombosis or intrahepatic metastasis, increased 
tumor size, a poorly differentiated phenotype and clinical stage. 
Losses occurring together on IJq, 16q and 17p were signifi-
cantly higher in patients in clinical stage IV or histologically 
poorly differentiated tumors, suggesting that the accumulation 
of allelic loss occurs in advanced tumors and that patients with 
multiple allelic losses may have a worse prognosis than those 
with a single loss. 
© 1992 Wiley-Liss, In c. 
Hepatoce llul ar carcinoma (HCC) is one of the most com-
mo n types of tu mor found, especi a ll y in Asia and Africa. 
Infect ion with hepat iti s B or C virus, chronic liver infl amm a-
tion and hepatic rege neration cern to be important ri sk 
factors for HCC (Beasley et a!. , 1981; Sakamoto et al., 1988; 
Sa ito et al., 1990) . However, li ttle is known about the ir ro le in 
HCC tumorigenesis. 
Loss-of-funct ion mutations of tumor- upprcssor genes may 
be very important in the ca rcinoge nesis of a va riety of hum an 
cancers (Lee et a!. , 1988; Vogelstcin et al. , 1988; Fong et al., 
1989; Win dle et a!. , 1990) . The mutation of a tum or-suppressor 
gene and sub equen t lo s of the corresponding norm al alle le 
have been observed as loss of specific chromosomes or chromo-
somal regions in tumor cell s. An excell ent model of the ge netic 
alterations occurring in the course of the deve lopment and 
progress ion of co lorcctal tumors has been propo cd (Fea ron 
and Vogclstcin , 1990) , in which a prefe rred ord er in each step 
of tumorigenesis was suggested . In tumors, such as renal-cell 
carcinom a, transitional-cell carcin oma of th e bl adder and 
ovaria n carc inom a, de letions of specific chromosomal regions 
we re also correlated well with clin ical and pathological param-
eters (O iu mi eta!. , 1990; Ogawa et a!. , 1991; Zhcng et a!. , 199 1 ). 
In human HCC, seve ral studies showed frequent loss of th e 
chromosomes 1p, 4q , 5q, I Oq, 11 p, 13q, 16q and 17p (Wang and 
Rogier, 1988; Buetow et a!., 1989; Zhang, W. et al., 1990; 
Fujimori et al., 1991; Sim on et a!., 199 1; Walker et al. , 199 1). 
Furthermore, the loss of chromosome 16 and changes in 
tumor-suppressor genes such as retinobl as toma (RB) and p53, 
were associated with tumor progress ion (Tsuda et a!. , 1990; 
Murakami et a!., 1991). 
To determ ine how all e lic losses on certain chromosomes are 
related to the initi ation and /or progress ion of HCC, we 
exami ned 56 hum an HCC for loss of heterozygosi ty (LOH) on 
chromosomes 4p, 11 p, J3q, 16q and 17p and analyzed th e 
rela tionship between LOH and the clini copa thologica l charac-
teristi cs of HCC. 
Since th e majority of HCCs were detected in cirrhotic liver 
and thi s condition is considered as a premalignant state, 
ti ssues from cirrhotic rege nerative nod ul es obtain ed from 42 
HCC pati ents were also analyzed to de term ine whe the r or not 
they had any LOH on th ese chromosomes. 
Some reports showed LOH on chromosome 13q in hum an 
HCC. As obse rved in RBs, osteosarco mas and lung ca ncers, 
the target of this 13q loss in HCC may be th e RB ge ne, sin ce 
LOH in th e RB locus was detected by using polymerase 
cha in -rcacti on- si nglc-s tra nd co nfo rm ati on po lymor ph ism 
(PCR- SSCP) and the brea kpoints of mitotic recombin ation or 
chromosomal deletion within the RB locus were also observed 
by using restriction fr agment length polymorphisms (RFLPs) 
on th e chromosome 13 (Wang and Rogier, 1988; Walker et al., 
199 1; Murakami et al., 199 1 ). To co nfirm thi s, we de let ion-
mapped chromosome 13q using 8 polymorphic probes, and 
also analyzed th e structural alteration of th e RB ge ne from 25 
pati ents by South ern hybridiza ti on using the RB eDNA. 
MATERI AL!\ D METII O DS 
Samples 
HCC ti ssues and periph era l lymph ocytes we re obtained 
from 56 HCC patients with informed consent. In 42 of th ese 
cases, rege nerative nodul es from ci rrhoti c ti sc ucs were also 
obtain ed from ne ighboring tumor ti ssues resec ted at the time 
of surgery. The demographic data of th e pati ents arc summ a-
rized in Tabl e I. The clini ca l stage of each patie nt was 
determined according to the class ifica tion given in the Ge nera l 
Ru les for th e Clinica l and Pathologica l Study of Prim ary Liver 
Ca ncer (Liver Ca nce r Study G roup of Japan, 1987). Opera-
tions were pe rformed at th e Kyo to U nive rsity Hospit al, and 
tum or and cirrhoti c ti ss ue sa mpl es were froze n immedia tely 
a ft er surgical remova l and stored at -80°C until DNA iso lat ion. 
Histological studies were perfo rmed at the Cl inica l Pathology 
Department of th e hospital and the histologica l grade of tumor 
differentiati on was ass igned acco rding to the Edmondson and 
Ste iner grading system ( 1954 ). Pe riph eral lymphocytes we re 
iso lated using Ficoii -Hypaq uc (Pharmacia, Uppsa la, Sweden) 
gradient centrifugation fro m heparinized blood obtained imme-
di ate ly before or a ft er the opera tion. 
DNA isolation and Southern blot analysis 
High-molecul ar-we ight DNA was iso lated fro m tumor ti s-
sues, cirrh otic non-ca ncero us ti ssues and per iphera l lymph o-
cytes, as previously described (Sambrook et al. , 1982). DNA 
sa mpl es were diges ted with appropria te restri ction endo nu-
clcases and e lectro phoresed in 0.8 or l .2o/c agarosc ge ls. The 
4To whom correspondence and reprint req uests shoul d be sent at 
the above address . Fax: 075-753-7564. 
Received: December 23 , lYY I and in revised form Marc h 9, 1992. 
l 
{ /.J )~ 
tCANlliR RESE ARCII ~JJ1. J,'\Jn u;uy 15, 19?JI 
H.olc and Mutational fleterogeneity of the p53 Gcue in llcpatoccllular Carcinon1a 1 
Naoshi Nishida, Yoshlhlro Fukuda, Uiroyukl Kokur)·u, Junya Toguchlda, David ·yy, Yandell, 1\llluo Ikcncga, 
Illroo Imura, and Kanji Ishlzaki~. 
71r~ Second D(pnnmnll of lntunnl M(dicin~ (N. N., r f. fl. K .. 11. 1./ nnd IJ~pnnlllrnt of Orrhnprwlic S11r~rr.v (1. T./. Fncrdry of Mrtficinr . l\'.mrn Uni, ·aJrr,: 5./ Knll'nlrnrn-clro, 
5/rn!(oin. 5nk:Yo -lw, 1\yoro: nnd Rndinrion /Jiolu.F Cortu (N. N .. J. T.. ,\[. /., K. !. /, Kyoto Unin·r.rir.': foshidn -k.ono,c/ro, 5nkyo·AII. 1\roto 6<M. Jnpnn : nnd liou·t Lnborntorv of 
Opluhalnrolos.': Massach11sOts £y, nnd Ear lnjimrar;.·, /Josron: MassacJwulls 021/.J (D. IY. Y./ 
AUSTRACT 
The mutational spectrum of the p53 gene was ::mnly:ud In 53 hcpnto-
ccttulnr carcino111ns. Somatic mutations of the pSJ gene were detected In 17 
cnsc:s (31%). Among these 17 mutations, 9 were missense mutntlons; the 
rnutallons In the other 8 cases were nonsense mutations, delctJons, or 
rnulatlons nt the in!ron~xon junctions. These mutnllons we~ found Inn 
wide region stretching frorn exon 4 to exon 10 without any single muta-
lion:tl hot spot. G:C to T:A trans~crsloll5 were pret.lomlnant, su~es!lng 
the lnvolve111ent of envlnmmenlnlmutngens In the rnutagenesls of the pSJ 
gene In a sui.Jsct of the hcpatocellulnr carcinorn::t c.1ses. l\lu!a!lons of the 
p53 gene occurred frcrJUently In advanced tumors, although scnrul tu-
mors In the enrly singes also showed mut.1tlons. A t.lcletion mnp of chro-
mosome 17 wns constructct.l by using 10 polymorphic probes nnd were 
cornparct.l with the pSJ gene mutations In each cnse. L<>ss or heterozygosity 
(LOll) on chromosome 17p wns observed In 49% of the cases (24 of 49), 
and two commonly tlrlr!ed regions were t.letectet.l (around the pSJ locus 
and at 17pl3.3 to !he telomere). Sixteen of the 17 cases with p53 gene 
mut..1lions showed LOll around the p53 Iucus, and mutations we~ rare In 
hepatocellular carcino111.as without LOll. llowever, no rnututlons we~ 
detected In 8 cases with LOll on 17p, suggesting the possiulll!y that an 
unldenlifietl tumor surp ressor gcnc(s) located on 17p may have also been 
lnvolnd in hcpatoc.:1rcinogenesls. \ 
INTRODUCTION 
IncrcJsing evidence h:1s supported the bet that the p53 gene acts JS 
a tumor suppressor gene ( 1 ). JIH..l mutations of the p53 gene are 
frequently found in a variety of cancers (2). Dressac er af. (3) reported 
an abnorni:.ll structure and expression of the p53 gene in HCC 3 . 
t.lcrived cell lil1es. In audition. a mutational hot spot at codon 249 
of the p53 gene wa..:; found in patients in China and South Afdcu, 
which was considered to be closely associated with dietary n!latoxin 
D1 intake (4-<J). In contrast. no such mutational hot spot has been 
reported thus far in Jnpanese HCC cases (7. R). suggesting the in-
volvement of different etiological factor(s). Therefore. an intensive 
analysis with a large number of samples is required to understand 
the mutational mechanism um..lerlying the p53 gene during hep:llo-
carcinogenesis. 
A study on colorectal carcinomas demonstrated that mutations of 
the p53 gene were closely associated with LOI ion 17p. a.ml vice versa 
(9). We have also reported that the LOI I on 17p in HCCs was strongly 
correlated with the nggressi vcncss of the tumor (I 0). suggesting a role 
for J15] gene inactivation in lhe progression of HCCs. 
Several recent stut.lics. however. have shown that the LOll on 
chromosome 17p was not necessarily associated with mutations of the 
Ji53 gene in tumors such as maJignant gliom:1s. ovarian c:1ncers. uml 
neuroectouenn:1l turnors (11-13). Allelotypic stuuies on IICCs and 
R~ccil'cd B/(,/92: ~cccptcd tll~/9~ . 
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breast cancers have olso revealeu a common ueleted region other than 
the p53 locus. which suggests that an unidentifieu tumor suppressor 
gene might be located on 17p (14. 15) . rurthermore. other tumor 
suppre:)sor genes such as NF-1. nm23. ant.! the prohibitin gene were 
rnappeu to the proxintal region or chromosome 17q (16. 17. 18). 
Therefore. it may be interesting to compare mutations of the p53 gene 
with the deletion rnup of chro111osomc 17 obtained from the sarnc 
l ICC samples. 
In this present study. we ha ve investigated the mutational profile of 
the p53 gene in 53 Japanese I ICC cases by PCR-SSCP analysis ;:~nu by 
direct genomic sequencing over the entire coding region. and com-
pareu these mutations with several clinical parameters. We also dele-
tion mapped chromosome 17 by using I U RrLP probes in the same 
tumor samples. ami analyzeu the relationship between mutations of 
the p53 gene and LOll. 
MATERIALS AND METHODS 
Samples. We uset.l 53 !ICC p~11icn1s. with U1eir informed consent, In this 
slutly. The patients unt.lerwcnt surgery nt Kyoto University Hospital, aml the 
tumors and surrounding noncancerous tissues were frozen immetliatcly after 
surgical removnl and storetl nt -so~c until Ute DNA isolation. The clinicJl 
stage of each patient was t.letermine<.l accort.ling 10 the cla.~silication scheme in 
tile General Rules for t11e Clinical nntl PntllUlogicnl Stutly of Prllllary Liver 
ramer ( 19). Histological studies were pcrfom1et.l at the Clinical Pntl1ology 
Oepartn1cnt of Llle hospital, nntllllsrotogic;-~1 grades were nssignec..l according ro 
Etlmonc..lson's grntling .~ystem (20). Among t11e cn.ses :JilJiyzcc..l, t10 were n1:1les 
ant.! 13 were felllales. furtl1ennorc, 7 putlcnls were p<Jsitive for serum hepatitis 
. D vlru~ surface antigen, nnu 46 were negntive. Eight cases were nl clinical 
stnge I, 7 were at stage II, 15 were ot ~lage Ill, and 23 cases were at 5t:~ge IV. 
DNA Isolation nnd Southern Ulot Analysis. lligh molecular weight DNA 
was isolatctl from U1e tulllor antl .~ urroundlng noncancerous tissues a.~ previ-
ously c..lescribeu (10). Restriclion endonuclease digestion. agarose gel electro-
photesis, Soutl1cn1 blot hybrit.lization, probe labeling by nick-tramlation, and 
autorat.liogr:1phy were also nil perfonncd as previously described {10). 
RFLP Probes. ll1e polymorphic probes u .~et.l in this stut.ly arc shown in 
TJble l. /'robes pYNII37 .3. pYNZ22, pMCT35.1, pllfl2- l. pl0.5, p/\10-"11. 
p!-tHfll52, pCMM86, antl plllll59 were a gilt fro111 Dr. Y. Nakarnurn. Probe 
pR4-2 was a giit from Dr. C. W. Miller. rurUter t.lctails of Utese probes ca11 be 
found in llurllJil Gene Mapping l J (21 ). 
PCR-RFLP Analysis. In nt.Jtlitionto /Jg/11 Rf=LP detected hy Sout11em ulnt 
nnnlysis with the pl\4-2 probe, we also nnalY7-etl Ute !JsrU I (;\cell) polynlur-
phism ut cotton 72, which can be detected by PCR-RfLP analysis (22). llle 
fourth cxon of the J153 gene W;J .~ ;unplif1ctl by using n pair of pri111crs which 
were the same n..~ those uset.J in the PCR -S SCP amlysi.~. The nrnplifiet.l DNA 
fr::~gnlclltS were lhen t.Jigestetl with 5 units of !JsrU l fur 4 It a.11t.J electruplturescu 
on 2% ngarose gels. 
PCR-SSCP nnd Dlrcd Sequencing. Each sa111plc was screencu for nwtn-
tions of Ute p53 gene by the PCR-SSCP 111ethtx.J. ns described by ToguchiuJ er 
rr/. (23). r=or SSCP, e:H.:h pair llf prirners wns tle~igneu to cover the entire cod ing 
region and the intron-exon junction .~. One huntlred ng of genomic DNA w<J .~ 
amplified in a buffer containing 0.1 pl [oYPjtlCTP (10 ntCi/ml). Thirty cycles 
of PCR were pcrfonneu, with 75 s of uctwturntiun at 94°C, 90s of a.11ncaling 
nt 52 or 60°C, a.11u 120 s of pulyn1erization nt 71 oc. 111e rcR prcxJuw were 
t.lilutcu 8-to 10-folt.l wiU1 0.1% sot.liutn dndccyl sulfnte ru1t.IIO 111M E;DTA, and 
then 111ixeu with the same volurne of t.lyc solution (95% rormamitle; 20 Tll.'l 
